FITC-equivalent Human CD20 Protein-Nanodisc (CD2-HM1N37)
CD2-HM1N37
Product group Proteins
Overview
- SupplierKACTUS
- Product NameFITC-equivalent Human CD20 Protein-Nanodisc (CD2-HM1N37)
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionB-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
- Storage Instruction-80°C
- UNSPSC12352202